Patent details

Basic Information

Publication number:

EP3023101

PCT Application Number:

JP2014069105

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP148268741

PCT Publication Number:

WO2015008844

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

THERAPEUTIC AGENT FOR FGFR INHIBITOR-RESISTANT CANCER

French Title of Invention:

AGENT THÉRAPEUTIQUE POUR UN CANCER RÉSISTANT À UN INHIBITEUR DE FGFR

German Title of Invention:

THERAPEUTIKUM FÜR FGFR-HEMMER-RESISTENTEN KREBS

SPC Number:

Dates

Filing date:

17/07/2014

Grant date:

19/08/2020

EP Publication Date:

25/05/2016

PCT Publication Date:

22/01/2015

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

19/08/2020

EP B1 Publication Date:

19/08/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

17/07/2021

Expiration date:

17/07/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

12/08/2020

 

 

Name:

Taiho Pharmaceutical Co., Ltd.

Address:

1-27, Kandanishiki-cho, Chiyoda-ku, Tokyo 101-8444, Japan (JP)

Inventor

Name:

SOOTOME, Hiroshi

Address:

Japan (JP)

Priority

Priority Number:

2013149958

Priority Date:

18/07/2013

Priority Country:

Japan (JP)

Classification

IPC classification:

A61K 31/404; A61K 31/437; A61K 31/44; A61K 31/47; A61K 31/496; A61K 31/5025; A61K 31/506; A61K 31/519; A61K 31/53; A61K 31/5377; A61P 35/00;

Publication

European Patent Bulletin

Issue number:

202034

Publication date:

19/08/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages